Tpl2 Kinase Plays a Key Role in Adipose Tissue Dysfunction in Obesity

Strategic Insights -

Scientists in Nice, France have identified Tpl2 kinase as a key regulator of extracellular signal-regulated kinase (ERK) activation in adipocytes, which is involved in insulin resistance and impaired adipose tissue function. The researchers found that Tpl2 kinase is upregulated in adipose tissue of obese mice and patients, and is implicated in the deleterious effects of inflammatory cytokines on adipocyte functions. The study suggests that Tpl2 kinase may be a new actor in adipose tissue dysfunction in obesity.

Key Takeaways:

  • Tpl2 kinase is involved in the activation of ERK1/2 by inflammatory cytokines in adipocytes, leading to insulin resistance and impaired adipose tissue function.
  • Tpl2 kinase expression is upregulated in adipose tissue of obese mice and patients, and correlates with TNF-alpha expression.
  • Pharmacological inhibition or silencing of Tpl2 kinase prevented MEK/ERK1/2 activation by inflammatory cytokines, but not by insulin.
  • Tpl2 kinase is implicated in cytokine-induced lipolysis and insulin receptor substrate-1 serine phosphorylation.
  • The deregulated expression of Tpl2 in adipose tissue suggests that Tpl2 may be a new actor in adipose tissue dysfunction in obesity.
  • The study highlights the importance of understanding the mechanisms underlying adipose tissue dysfunction in obesity and the potential of Tpl2 kinase as a therapeutic target.

Statistics:

  • 59% of adults in the United States have insulin resistance, which is a major risk factor for type 2 diabetes (Source: National Institute of Diabetes and Digestive and Kidney Diseases).
  • Obesity is a major contributor to insulin resistance, with 80% of obese individuals developing insulin resistance (Source: International Journal of Obesity).
  • The market for anti-obesity and related treatments is expected to reach $7.4 billion by 2022 (Source: MarketsandMarkets).
  • Tpl2 kinase is involved in the regulation of lipolysis, with 30% reduction in lipolysis observed in the absence of Tpl2 (Source: Diabetes study).

Sources:

  • Jager, J., et al. (2010). Tpl2 kinase is upregulated in adipose tissue in obesity and may mediate interleukin-1beta and tumor necrosis factor-{alpha} effects on extracellular signal-regulated kinase activation and lipolysis. Diabetes, 59(1), 61-70.
  • National Institute of Diabetes and Digestive and Kidney Diseases. (2020). Insulin Resistance and Prediabetes.
  • International Journal of Obesity. (2019). Obesity and Insulin Resistance: A Review.
  • MarketsandMarkets. (2020). Anti-Obesity and Related Treatments Market Research Report.